Ask AI
Type 2 diabetes and obesity 2025 ADA highlights

CME

Expanding Treatment Options for Type 2 Diabetes and Overweight/Obesity: Highlights From the 2025 ADA Annual Meeting

Physicians: Maximum of 0.25 AMA PRA Category 1 Credit

Released: July 08, 2025

Expiration: July 07, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

How frequently do you evaluate the safety, efficacy, and patient adherence factors when initiating or switching to newly approved or emerging therapies for patients with T2D?